Groups Pledge Funding for Project to Develop Ovarian Cancer Blood Test

Groups Pledge Funding for Project to Develop Ovarian Cancer Blood Test
A team at Griffith University’s Institute for Glycomics in Australia has received $300,000 in funding from The Bourne Foundation, as well as a further funding pledge from Tour de Cure, to advance research into the development of blood tests for the early diagnosis of ovarian cancer. "Despite decades of research, there is currently no easily accessible, non-invasive and reliable early detection test to diagnose ovarian cancer, which leads to poor survivability rates," Michael Jennings, PhD, a Griffith University professor who will work on the project, said in a press release. Cancers are easiest to treat when they are small and contained to a single location; in such instances, a tumor often can be removed completely via surgery. However, many people with ovarian cancer are not diagnosed until relatively late in the disease, when the tumor is comparatively large and may have spread to multiple locations in the body. Late diagnosis makes treatment more difficult, ultimately resulting in worse outcomes. "With no substantial improvement in ovarian cancer survival rates over the past two decades, the key to ovarian cancer survival lies in the development of better diagnostic methods," Jennings said. "If diagnosed early, over 90% of ovarian cancer patients could be cured. [Tumors] that are detected early before they have had a chance to spread
Subscribe or to access all post and page content.